Bristol Myers Squibb (BMY) FCF Payout Ratio (2009 - 2026)

Bristol Myers Squibb (BMY) has reported FCF Payout Ratio for 18 consecutive years, with 0.42 the latest figure, recorded in Q2 2026.

• On a quarterly basis, FCF Payout Ratio rose 17.44% year-over-year to 0.42 in Q2 2026; TTM through Jun 2026 was 0.45, a 31.06% increase from a year earlier, with the FY2025 full-year figure at 0.39, up 12.6% from the prior year.
• FCF Payout Ratio was 0.42 for Q2 2026 at Bristol Myers Squibb, down from 1.69 in the prior quarter.
• Over five years, FCF Payout Ratio peaked at 1.69 in Q1 2026 and troughed at 0.01 in Q2 2022.
• A 5-year average of 0.48 and a median of 0.37 in 2022 frame the typical range for FCF Payout Ratio.
• Across the five-year window, FCF Payout Ratio jumped 12086.9% in 2023 and plunged 39.81% in 2025, its largest moves.
• Over 5 years, FCF Payout Ratio stood at 0.39 in 2022, then declined by 23.54% to 0.3 in 2023, then rose by 1.41% to 0.3 in 2024, then soared by 162.33% to 0.79 in 2025, then plunged by 47.03% to 0.42 in 2026.
• The last three FCF Payout Ratio figures came in at 0.42 (Q2 2026), 1.69 (Q1 2026), and 0.79 (Q4 2025), per Business Quant data.